1-Methylpiperazine → HCID 20554355, 화합물

HRID 1106027노트

반응식

HRID 1106027 반응식
[CH3:1][N:2]1[CH2:7][CH2:6][NH:5][CH2:4][CH2:3]1.Cl[CH2:9][C:10]([N:12]1[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[N:16]([CH3:23])[C:15](=[O:24])[C:14]2[CH:25]=[N:26][CH:27]=[N:28][C:13]1=2)=[O:11].C(=O)(O)[O-].[Na+]>C1C=CC=CC=1>[CH3:23][N:16]1[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=2[N:12]([C:10](=[O:11])[CH2:9][N:5]2[CH2:6][CH2:7][N:2]([CH3:1])[CH2:3][CH2:4]2)[C:13]2[N:28]=[CH:27][N:26]=[CH:25][C:14]=2[C:15]1=[O:24]

참가 물질

5

반응물 3

HCID 531671-MethylpiperazineHCID 516892Sodium BicarbonateHCID 20554401HCID 20554401, 화합물

생성물 1

HCID 20554355HCID 20554355, 화합물

시약·촉매·용매 1

HCID 241Benzene용매

반응 조건

온도
70 °C

실험 절차

2.6 g (0.0266 mol) of N-methylpiperazine are added dropwise at 50° C., in the course of 15 minutes, to a suspension of 4.0 g (0.0133 mol) of 11-chloroacetyl-6-methyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-one in 30 ml of absolute benzene, and the mixture is stirred for a further 1.5 hours at 70° C. After cooling, the mixture is poured into 100 ml of saturated sodium bicarbonate solution and is extracted once with 50 ml of ethyl acetate and twice with 100 ml, each time, of chloroform. After drying, the organic phase is concentrated in vacuo, and the liquid residue is induced to crystallize by means of ether. It is purified by filtering through neutral silica gel (elution with chloroform) and evaporating the filtrate; yield: 2.7 g, m.p. 183° to 185° C.

후처리

  1. temperatureAfter cooling
  2. extractionis extracted once with 50 ml of ethyl acetate and twice with 100 ml
  3. customAfter drying
  4. concentrationthe organic phase is concentrated in vacuo
  5. customto crystallize by means of ether
  6. customIt is purified
  7. filtrationby filtering through neutral silica gel (elution with chloroform)
  8. customevaporating the filtrate

출처 및 근거

ORD 기록
ord-6898a588d5d343bbb43b4a8e2a4951ab
출처 데이터셋
uspto-grants-1982_01
특허 번호
US04311700

반응 노트

불러오는 중…